RACTIGEN

Ractigen Therapeutics, a clinical-stage pharmaceutical company, specializes in developing pioneering therapies aimed at enhancing the expression of therapeutic genes within diseased cells... Founded in 2017 by the trailblazers in RNA activation (RNAa) research, Ractigen Therapeutics was established with a mission to develop a new generation of medicines. The company focuses on treating diseases that arise from inadequate gene expression, leveraging the expertise of its founders to create an innovative pipeline of therapeutic solutions... We are an clinical-stage pharmaceutical company creating first-in-class therapies designed to boost expression of therapeutic genes in diseased cells.

Also known as: Ractigen Therapeutics

Primary location: Suzhou China